Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Musculoskeletal Disorders
Published in: BMC Musculoskeletal Disorders 1/2006

Open Access 01-12-2006 | Research article

Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis

Authors: Maria LE Andersson, Carina A Thorstensson, Ewa M Roos, Ingemar F Petersson, Dick Heinegård, Tore Saxne

Published in: BMC Musculoskeletal Disorders | Issue 1/2006

Login to get access

Abstract

Background

COMP (Cartilage oligomeric matrix protein) is a matrix protein, which is currently studied as a potential serum marker for cartilage processes in osteoarthritis (OA). The influence of physical exercise on serum COMP is not fully elucidated.
The objective of the present study was to monitor serum levels of COMP during a randomised controlled trial of physical exercise vs. standardised rest in individuals with symptomatic and radiographic knee OA.

Methods

Blood samples were collected from 58 individuals at predefined time points before and after exercise or rest, one training group and one control group. The physical exercise consisted of a one-hour supervised session twice a week and daily home exercises. In a second supplementary study 7 individuals were subjected to the same exercise program and sampling of blood was performed at fixed intervals before, immediately after, 30 and 60 minutes after the exercise session and then with 60 minutes interval for another five hours after exercise to monitor the short-term changes of serum COMP. COMP was quantified with a sandwich-ELISA (AnaMar Medical, Lund, Sweden).

Results

Before exercise or rest no significant differences in COMP levels were seen between the groups. After 60 minutes exercise serum COMP levels increased (p < 0.001). After 60 minutes of rest the serum levels decreased (p = 0.003). Median serum COMP values in samples obtained prior to exercise or rest at baseline and after 24 weeks did not change between start and end of the study. In the second study serum COMP was increased immediately after exercise (p = 0.018) and had decreased to baseline levels after 30 minutes.

Conclusion

Serum COMP levels increased during exercise in individuals with knee OA, whereas levels decreased during rest. The increased serum COMP levels were normalized 30 minutes after exercise session, therefore we suggest that samples of blood for analysis of serum COMP should be drawn after at least 30 minutes rest in a seated position. No increase was seen after a six-week exercise program indicating that any effect of individualized supervised exercise on cartilage turnover is transient.
Appendix
Available only for authorised users
Literature
1.
Brandt K, Doherty M, Lohmander S: Pathogenesis of osteoarthritis – Introduction. Osteoarthritis. Edited by: Brandt KDM, Lohmander S. 1998, Oxford: Oxford University Press, 70-73.
2.
Petersson IF, Jacobsson LT: Osteoarthritis of the peripheral joints. Best Pract Res Clin Rheumatol. 2002, 16: 741-760. 10.1053/berh.2002.0266.CrossRefPubMed
3.
Thorstensson CA, Petersson IF, Jacobsson LT, Boegard TL, Roos EM: Reduced functional performance in the lower extremity predicted radiographic knee osteoarthritis five years later. Ann Rheum Dis. 2004, 63: 402-407. 10.1136/ard.2003.007583.CrossRefPubMedPubMedCentral
4.
Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P: EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003, 62: 1145-1155. 10.1136/ard.2003.011742.CrossRefPubMedPubMedCentral
5.
Ettinger WH, Burns R, Messier SP, Applegate W, Rejeski WJ, Morgan T, Shumaker S, Berry MJ, O'Toole M, Monu J, Craven T: A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). JAMA. 1997, 277: 25-31. 10.1001/jama.277.1.25.CrossRefPubMed
6.
Rogind H, Bibow-Nielsen B, Jensen B, Moller HC, Frimodt-Moller H, Bliddal H: The effects of a physical training program on patients with osteoarthritis of the knees. Arch Phys Med Rehabil. 1998, 79: 1421-1427. 10.1016/S0003-9993(98)90238-6.CrossRefPubMed
7.
Deyle GD, Henderson NE, Matekel RL, Ryder MG, Garber MB, Allison SC: Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee. A randomized, controlled trial. Ann Intern Med. 2000, 132: 173-181.CrossRefPubMed
8.
Roos H, Dahlberg L, Hoerrner LA, Lark MW, Thonar EJ, Shinmei M, Lindqvist U, Lohmander LS: Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise. Osteoarthritis Cartilage. 1995, 3: 7-14. 10.1016/S1063-4584(05)80033-0.CrossRefPubMed
9.
Roos EM, Dahlberg L: Positive effects of moderate exercise on glycosaminoglycan content in knee cartilage: A four-month, randomized, controlled trial in patients at risk of osteoarthritis. Arthritis Rheum. 2005, 52: 3507-3514. 10.1002/art.21415.CrossRefPubMed
10.
Giannoni P, Siegrist M, Hunziker EB, Wong M: The mechanosensitivity of cartilage oligomeric matrix protein (COMP). Biorheology. 2003, 40: 101-109.PubMed
11.
Wong M, Siegrist M, Cao X: Cyclic compression of articular cartilage explants is associated with progressive consolidation and altered expression pattern of extracellular matrix proteins. Matrix Biol. 1999, 18: 391-399. 10.1016/S0945-053X(99)00029-3.CrossRefPubMed
12.
Saxne T, Månsson B, Heinegård D: Molecular markers for assessment of cartilage damage in rheumatoid arthritis. Rheumatoid Arthritis. Edited by: Firestein GS, Panayi GS, Wollheim FA. 2006, New York: Oxford University Press, 301-316. 2
13.
Poole AR: Biochemical/immunochemical biomarkers of osteoarthritis: utility for prediction of incident or progressive osteoarthritis. Rheum Dis Clin North Am. 2003, 29: 803-818. 10.1016/S0889-857X(03)00056-5.CrossRefPubMed
14.
Kraus VB: Biomarkers in osteoarthritis. Curr Opin Rheumatol. 2005, 17: 641-646. 10.1097/01.bor.0000174195.15421.17.CrossRefPubMed
15.
Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D: Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem. 1992, 267: 6132-6136.PubMed
16.
Saxne T, Heinegard D: Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol. 1992, 31: 583-591.CrossRefPubMed
17.
Heinegård D, Lorenzo P, Saxne T: Matrix Glycoproteins and Proteoglycans in Cartilage. Kelley's Textbook of Rheumatology. Edited by: Harris ED, Budd RC, Firestein GS, Genovese MC, Ruddy S. 2005, Philadelphia: Elsevier Saunders, 48-62.
18.
Larsson E, Erlandsson Harris H, Lorentzen JC, Larsson A, Mansson B, Klareskog L, Saxne T: Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats. Rheumatology (Oxford). 2002, 41: 996-1000. 10.1093/rheumatology/41.9.996.CrossRef
19.
Larsson E, Erlandsson Harris H, Larsson A, Mansson B, Saxne T, Klareskog L: Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatology (Oxford). 2004, 43: 428-434. 10.1093/rheumatology/keh073.CrossRef
20.
Crnkic M, Mansson B, Larsson L, Geborek P, Heinegard D, Saxne T: Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther. 2003, 5: R181-185. 10.1186/ar760.CrossRefPubMedPubMedCentral
21.
Petersson IF, Boegard T, Svensson B, Heinegard D, Saxne T: Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol. 1998, 37: 46-50. 10.1093/rheumatology/37.1.46.CrossRefPubMed
22.
Mansson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, Heinegard D, Saxne T: Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest. 1995, 95: 1071-1077.CrossRefPubMedPubMedCentral
23.
Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S: Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum. 2004, 50: 2479-2488. 10.1002/art.20365.CrossRefPubMed
24.
Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T: Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis. 2005, 64: 196-201. 10.1136/ard.2003.019992.CrossRefPubMed
25.
Thorstensson CA, Roos EM, Petersson IF, Ekdahl C: Six-week high-intensity exercise program for middle-aged patients with knee osteoarthritis: a randomized controlled trial [ISRCTN20244858]. BMC Musculoskelet Disord. 2005, 6: 27-10.1186/1471-2474-6-27.CrossRefPubMedPubMedCentral
26.
Mundermann A, Dyrby CO, Andriacchi TP, King KB: Serum concentration of cartilage oligomeric matrix protein (COMP) is sensitive to physiological cyclic loading in healthy adults. Osteoarthritis Cartilage. 2005, 13: 34-38. 10.1016/j.joca.2004.09.007.CrossRefPubMed
27.
Neidhart M, Muller-Ladner U, Frey W, Bosserhoff AK, Colombani PC, Frey-Rindova P, Hummel KM, Gay RE, Hauselmann H, Gay S: Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage. 2000, 8: 222-229. 10.1053/joca.1999.0293.CrossRefPubMed
28.
Andersson ML, Petersson IF, Karlsson KE, Jonsson EN, Mansson B, Heinegard D, Saxne T: Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis. Ann Rheum Dis. 2006, 65: 1490-1494. 10.1136/ard.2005.051292.CrossRefPubMedPubMedCentral
Metadata
Title
Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
Authors
Maria LE Andersson
Carina A Thorstensson
Ewa M Roos
Ingemar F Petersson
Dick Heinegård
Tore Saxne
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2006
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-7-98

Other articles of this Issue 1/2006

BMC Musculoskeletal Disorders 1/2006 Go to the issue

Research article

Does patient-physiotherapist agreement influence the outcome of low back pain? A prospective cohort study

Technical advance

Quantitative ultrasound tissue characterization in shoulder and thigh muscles – a new approach

Research article

Musculoskeletal disorders in shipyard industry: prevalence, health care use, and absenteeism

Study protocol

Effectiveness of joint mobilisation after cast immobilisation for ankle fracture: a protocol for a randomised controlled trial [ACTRN012605000143628]

Study protocol

Design of the PROCON trial: a prospective, randomized multi – center study comparing cervical anterior discectomy without fusion, with fusion or with arthroplasty

Research article

Primary care consultation, hospital admission, sick leave and disability pension owing to neck and low back pain: a 12-year prospective cohort study in a rural population